102 related articles for article (PubMed ID: 2560154)
1. 99Tcm(v)-DMSA planar scintigraphy: does it have a role in the management of patients with head and neck squamous carcinoma?
Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1989 Dec; 10(12):859-70. PubMed ID: 2560154
[TBL] [Abstract][Full Text] [Related]
2. 99Tcm (v) DMSA: a clinical, planar and SPECT study to evaluate patients with head and neck squamous carcinoma.
Watkinson JC; Lazarus CR; Mistry R; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Feb; 11(2):111-20. PubMed ID: 2162509
[TBL] [Abstract][Full Text] [Related]
3. 99Tcm (v) DMSA and 67Ga-citrate imaging in patients with head and neck squamous carcinoma: a clinical and scintigraphic study.
Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Feb; 11(2):103-10. PubMed ID: 2162508
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m(v) dimercaptosuccinic acid planar scintigraphy in head and neck cancer: clinical, scintigraphic and radiological study.
Watkinson JC; Todd CE; Lazarus CR; Maisey MN; Clarke SE
J Laryngol Otol; 1990 Oct; 104(10):783-9. PubMed ID: 2174074
[TBL] [Abstract][Full Text] [Related]
5. Metastatic squamous carcinoma in the neck: an anatomical and physiological study using CT and SPECT 99Tcm (V) DMSA.
Watkinson JC; Lazarus CR; Todd C; Maisey MN; Clarke SE
Br J Radiol; 1991 Oct; 64(766):909-14. PubMed ID: 1659474
[TBL] [Abstract][Full Text] [Related]
6. What is the optimal imaging time for 99Tcm-(V)-DMSA planar scintigraphy in the detection of squamous carcinoma? A comparative study in humans and in an animal tumour model.
Watkinson JC; Allen S; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1989 Oct; 10(10):741-50. PubMed ID: 2559379
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m (v) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: experience in imaging.
Watkinson JC; Lazarus CR; Mistry R; Shaheen OH; Maisey MN; Clarke SE
J Nucl Med; 1989 Feb; 30(2):174-80. PubMed ID: 2544690
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, biodistribution and dosimetry of 99Tcm(V)DMSA in humans with squamous cell carcinoma.
Watkinson JC; Allen S; Lazarus CR; Sinclair J; Blake GM; Clarke SE
Nucl Med Commun; 1990 May; 11(5):343-59. PubMed ID: 2164650
[TBL] [Abstract][Full Text] [Related]
9. 99Tcm (v) DMSA: the pituitary sign.
Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Apr; 11(4):313-7. PubMed ID: 2163501
[TBL] [Abstract][Full Text] [Related]
10. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
[TBL] [Abstract][Full Text] [Related]
11. Metastatic carcinoma in the neck: a clinical, radiological, scintigraphic and pathological study.
Watkinson JC; Todd CE; Paskin L; Rankin S; Palmer T; Shaheen OH; Clarke SE
Clin Otolaryngol Allied Sci; 1991 Apr; 16(2):187-92. PubMed ID: 1649018
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m (v) dimercaptosuccinic acid: a clinical and scintigraphic study in an animal tumour model.
Watkinson JC; Allen S; Lazarus CR; Laws D; Hibbert J; Clarke SE
Clin Otolaryngol Allied Sci; 1990 Dec; 15(6):497-501. PubMed ID: 1963580
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the uptake of technetium-99m (v) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck.
Watkinson JC; Clarke SE; Shaheen OH
Clin Otolaryngol Allied Sci; 1987 Dec; 12(6):405-11. PubMed ID: 2832106
[TBL] [Abstract][Full Text] [Related]
14. Subcellular biodistribution of 99Tcm(V) DMSA in squamous carcinoma: a comparative study in humans and in an animal tumour model.
Watkinson JC; Allen S; Higgins M; Bharij A; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Aug; 11(8):547-55. PubMed ID: 2170881
[TBL] [Abstract][Full Text] [Related]
15. 99Tcm(V) DMSA: what is its current role in the management of patients with head and neck cancer?
Watkinson J; Clarke S
Nucl Med Commun; 1991 Feb; 12(2):79-82. PubMed ID: 1848360
[No Abstract] [Full Text] [Related]
16. [Scintigraphic imaging of head and neck cancers with 99m technetium (v) dimercaptosuccinic acid. A prospective clinical study].
Heinritz H; Marienhagen J; Wolf F; Schuster B; Stenglein C; Iro H
HNO; 1992 Nov; 40(11):437-41. PubMed ID: 1335446
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.
Ohta H; Endo K; Fujita T; Konishi J; Torizuka K; Horiuchi K; Yokoyama A
Nucl Med Commun; 1988 Feb; 9(2):105-16. PubMed ID: 2838772
[TBL] [Abstract][Full Text] [Related]
18. [Scintigraphic observation of cancer with 99mTc(V)-DMS].
Ohta J; Endo K; Kotoura Y; Torizuka K
Rinsho Hoshasen; 1984 Aug; 29(8):935-6. PubMed ID: 6096599
[No Abstract] [Full Text] [Related]
19. The detection of nasopharynx carcinoma in technetium-99m (V) dimercaptosuccinic acid SPECT imaging.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Clin Nucl Med; 1993 Apr; 18(4):321-3. PubMed ID: 8386992
[TBL] [Abstract][Full Text] [Related]
20. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus C; Mistry R; Maisey MN
Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
